Campbell & CO Investment Adviser LLC Takes $2.87 Million Position in Addus HomeCare Corporation $ADUS

Key Points

• Campbell & CO Investment Adviser LLC acquired a new stake in Addus HomeCare Corporation, purchasing 28,970 shares valued at approximately $2.865 million during the first quarter.
• Insiders have sold a total of 28,616 shares of Addus HomeCare stock over the last three months, indicating significant insider trading activity.
• Addus HomeCare reported a 21.8% year-over-year revenue increase for its recent quarter, with earnings per share of $1.49, exceeding analysts' expectations.

Campbell & CO Investment Adviser LLC bought a new position in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the first quarter, according to the company in its most recent disclosure with the SEC. The fund bought 28,970 shares of the company's stock, valued at approximately $2,865,000. Campbell & CO Investment Adviser LLC owned 0.16% of Addus HomeCare at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Premier Fund Managers Ltd bought a new stake in Addus HomeCare in the 1st quarter worth approximately $726,000. Deutsche Bank AG grew its position in shares of Addus HomeCare by 50.0% during the 4th quarter. Deutsche Bank AG now owns 16,354 shares of the company's stock valued at $2,050,000 after acquiring an additional 5,448 shares during the period. Dimensional Fund Advisors LP grew its position in shares of Addus HomeCare by 1.5% during the 4th quarter. Dimensional Fund Advisors LP now owns 692,713 shares of the company's stock valued at $86,833,000 after acquiring an additional 10,434 shares during the period. Bank of America Corp DE grew its position in shares of Addus HomeCare by 273.6% during the 4th quarter. Bank of America Corp DE now owns 175,070 shares of the company's stock valued at $21,945,000 after acquiring an additional 128,211 shares during the period. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main grew its position in shares of Addus HomeCare by 77.6% during the 4th quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 8,836 shares of the company's stock valued at $1,108,000 after acquiring an additional 3,862 shares during the period. Institutional investors own 95.35% of the company's stock.

Addus HomeCare Price Performance

ADUS stock traded down $2.50 during mid-day trading on Tuesday, hitting $114.15. The company had a trading volume of 102,299 shares, compared to its average volume of 203,027. The company has a market capitalization of $2.10 billion, a price-to-earnings ratio of 25.20, a P/E/G ratio of 1.78 and a beta of 0.80. Addus HomeCare Corporation has a 12-month low of $88.96 and a 12-month high of $136.72. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17. The company has a 50-day moving average price of $112.02 and a 200 day moving average price of $106.95.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its quarterly earnings results on Monday, August 4th. The company reported $1.49 EPS for the quarter, topping the consensus estimate of $1.45 by $0.04. The business had revenue of $349.44 million for the quarter, compared to analysts' expectations of $345.71 million. Addus HomeCare had a net margin of 6.51% and a return on equity of 9.39%. The business's quarterly revenue was up 21.8% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.35 EPS. On average, research analysts anticipate that Addus HomeCare Corporation will post 4.59 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on ADUS shares. Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a research report on Sunday, June 29th. Royal Bank Of Canada boosted their price objective on shares of Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a research report on Friday. Barclays boosted their price objective on shares of Addus HomeCare from $83.00 to $109.00 and gave the company an "underweight" rating in a research report on Tuesday, August 19th. Macquarie reissued an "outperform" rating and set a $133.00 price objective on shares of Addus HomeCare in a research report on Tuesday, June 10th. Finally, JMP Securities reissued a "market outperform" rating and set a $150.00 price objective on shares of Addus HomeCare in a research report on Wednesday, July 16th. Two equities research analysts have rated the stock with a Strong Buy rating, six have issued a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Addus HomeCare presently has an average rating of "Buy" and an average target price of $138.38.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Brian Poff sold 7,739 shares of the business's stock in a transaction on Monday, August 25th. The shares were sold at an average price of $116.82, for a total value of $904,069.98. Following the sale, the executive vice president owned 56,980 shares in the company, valued at $6,656,403.60. The trade was a 11.96% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total transaction of $2,873,750.00. Following the sale, the chief executive officer owned 166,461 shares in the company, valued at $19,134,691.95. This represents a 13.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 34,310 shares of company stock worth $3,958,375 in the last 90 days. 4.50% of the stock is currently owned by corporate insiders.

Addus HomeCare Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.